• Proactive MD Reports Third Transaction of 2026 

    On January 16, Proactive MD announced that it acquired undisclosed allergy specialist practices in Virginia. Terms were not disclosed.  Proactive MD is a value-based care provider dedicated to transforming healthcare for patients, employers and health plan partners through integrated solutions. Its integrated model offers centralized... Read More »
  • GSK Acquires Rapt Therapeutics For $2.2 Billion 

    In its first transaction of the year, GSK Plc, announced that it acquired Rapt Therapeutics, Inc. for $58 per share.  That price equates to an aggregate equity value of $2.2 billion, according to GSK, which added that the upfront investment net of cash acquired comes to $1.9 billion. Net of cash acquired, GSK’s estimated upfront investment... Read More »
  • Worldwide Clinical Trials to Acquire Catalyst Clinical Research

    Worldwide Clinical Trials, a global contract research organization (CRO), announced on January 20 that it will be acquiring Wilmington, North Carolina-headquartered Catalyst Clinical Research, LLC. Financial terms of the deal were not disclosed. Catalyst Clinical Research, LLC is a specialized CRO delivering customizable clinical research... Read More »
  • Most Active Physician Group Buyers of 2025

    The deal volume in the Physician Medical Group (PMG) sector was strong throughout 2025, totaling 521 transactions, surpassing the 506 reported in 2024. The subsectors with the most activity were dental (248 deals), eye care (34), dermatology (32) and orthopaedic (31).  The sector’s year-over-year stability is due to strong competition... Read More »
  • ACES Acquires Ally Pediatric Therapy

    ACES announced that it is bolstering its services in Arizona with the acquisition of Paradise Valley-based Ally Pediatric Therapy. Founded in 2017, Ally Pediatric Therapy is a leading provider of applied behavior analysis (ABA) therapy and speech-language therapy to children and young adults with autism and other childhood disorders. Ally... Read More »

eHealth Deals Soar in 2019

It almost goes without saying that technology has permeated every aspect of healthcare, but dealmaking in 2019 underscores that point even further. Based on preliminary numbers, eHealth deals hit a record 212 this year, a slight uptick from 2018’s deal count of 204, according to our Deal Search Online database. Source: HealthcareMandA.com, December 2019 The graph above breaks out the number of deals by target type. Companies focused on providing management software solutions to support back-office operations led the sector this year, with 46 deals. These are usually small firms offering software-as-a-service (SaaS) platforms that could be implemented to aid any type of healthcare... Read More »
Hospice Deals Heat Up

Hospice Deals Heat Up

It’s been a busy year in the Home Health & Hospice sector. Deal volume is poised to surpass the record 85 transactions announced in 2018. Through late November, 79 deals are in our DealSearchOnline database and more are expected before year-end. Home health agencies account for the bulk of the transactions every year, making up 72% in both 2015 and 2016, for example. In the past two years, however, hospice companies have seen a surge in investor interest. In 2018, hospice companies accounted for 33% of the 85 deals in the sector. Through the end of November 2019, they make up 38% of the sector’s deal count. Valuations are often described as “frothy” for home... Read More »
Lumenis Finally Finds a Buyer

Lumenis Finally Finds a Buyer

After a four-year partnership, XIO Group has finally sold Lumenis. CVC Capital Partners and FountainVest Partners came incredibly close to purchasing the medical device firm late last year for an estimated $950 million, according to reports in Calcalist, but the deal was never finalized. Fast forward to the present day, and Baring Private Equity Asia (BPEA) has emerged as the buyer, spending $1 billion for the Israeli firm. Lumenis provides specialty minimally invasive medical devices in the fields of aesthetics, urology, ophthalmology, ENT, and gynecology. The company has a presence in more than 100 countries. XIO Group acquired Lumenis in 2015 for $510 million, or $14 a share, when the... Read More »
LGC Gets New Owners After Multi-Billion Deal

LGC Gets New Owners After Multi-Billion Deal

Cinven and Astorg have joined forces to purchase LGC Group from KKR (NYSE: KKR). The two global private equity firms spent $3.88 billion (£3 billion) for the firm, according to sources cited in Private Equity News. LGC provides a range of measurement tools, proficiency testing schemes, supply chain assurance standards, and specialty genomics reagents to the life sciences industry. According to our Deal Search Online database, this is the largest deal in the Laboratories, MRI and Dialysis sector, based on disclosed prices in 2019. This deal ends a four-year partnership that started in December 2015 when KKR acquired LGC for $989 million. At the time, LGC was a portfolio company of... Read More »
Lumenis Finally Finds a Buyer

PE Firms Trade WIRB-Copernicus for $3 Billion

Leonard Green & Partners, L.P won the auction to acquire WIRB-Copernicus Group (WCG) from Arsenal Capital Partners for $3 billion. The purchase value was originally reported in PE Hub Buyouts. WCG is a clinical services organization that enables biopharmaceutical companies, contract research organizations and institutions to accelerate the delivery of new treatments and therapies to patients. Arsenal will retain a stake in WCG. It acquired the company in March 2012 and led its recapitalization in August 2016 alongside other investors, including MSD Partners, the family office of Michael Dell. WCG has an estimated EBITDA of $175 million for 2019. WCG has been relatively quiet on the... Read More »
Doc Group Deals Take Health Care in New Directions

Doc Group Deals Take Health Care in New Directions

With more than 180 deals announced so far in 2019, the Physician Medical Group sector is roaring toward another strong close. The usual specialties—dental, dermatology and ophthalmology—are still very active, but after 10 to 20 years of consolidation, their trajectories are flattening. Other specialties are gaining traction with private equity investors, particularly orthopedics, gastrointestinal (GI), urology, pain management and women’s health. Even ear, nose & throat (ENT) deals are picking up. We spoke with a few deal makers to find out where this sector stands at the end of 2019 and what’s ahead for M&A in 2020. The hot areas this year have been surgical subspecialties,... Read More »